Neurim Pharmaceuticals Ltdis A Drug Discovery And Development Company Focused On Neuroscienceestablished In 1991 By Nava Zisapel And Yehuda Zisapelbased In Tel Avivisraelthe Company Specializes In Central Nervous Systemcnstherapeuticsaiming To Meet Unmet Patient Needs With Innovative Pharmaceutical Solutions Neurim Develops Treatments For Sleep Disordersneurodegenerative Diseasesand Cognitive Impairmentsleveraging Its Expertise In Circadian Rhythm Biology And Neuropharmacologyits Notable Products Include Circadina A Prolonged Release Melatonin Formulation For Insomniaand Slenytoa A Pediatric Melatonin Productthe Company Is Also Advancing Piromelatinean Investigational Drug For Insomnia Currently In Phase Ii Trialsneurim S Pipeline Includes Candidates Targeting Alzheimerae S Dementia And Sleep Apneafocusing On Conditions With Significant Market Potential With A Small Team Of Around 20 Employeesneurim Reported Revenue Of $5 8 Millionthe Company Collaborates With Academic Institutions And Pharmaceutical Leaders To Enhance Its Research And Development Effortsmaintaining A Global Presence Through Product Distribution And Licensing Agreements
No conferences found for this company.
| Company Name | Neurim Pharmaceuticals Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
